Search research articles
Contact Us
Filters
Showing results (81-90 of 106) with videos related to
Page
of 11
Sort By:
Oncology Research
|
January 1, 1995
Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833
J P Jaffrézou, C Dumontet, W B Derry, et al.
Bone Marrow Transplantation
|
December 8, 2009
Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
C Dumontet, S Landi, T Reiman, et al.
Leukemia
|
August 11, 1998
Mantle cell lymphoma: a retrospective study of 121 cases
H Samaha, C Dumontet, N Ketterer, et al.
The Journal of Rheumatology
|
February 11, 1999
Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes
P Duhaut, S Bosshard, A Calvet, et al.
British Journal of Cancer
|
September 15, 2001
Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity
C M Galmarini, N Falette, E Tabone, et al.
Leukemia Research
|
January 26, 2010
A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment
J-P Annereau, V Brel, C Dumontet, et al.
Cancer Research
|
June 30, 2001
Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis
A Mialhe, L Lafanechère, I Treilleux, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 16, 2011
Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains
A Doléans-Jordheim, E Bergeron, F Bereyziat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
F Morschhauser, S Depil, E Jourdan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults
O Hequet, Q H Le, I Moullet, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 106) with videos related to
Sort By:
Page
of 11
Oncology Research
|
January 1, 1995
Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833
J P Jaffrézou, C Dumontet, W B Derry, et al.
Bone Marrow Transplantation
|
December 8, 2009
Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan
C Dumontet, S Landi, T Reiman, et al.
Leukemia
|
August 11, 1998
Mantle cell lymphoma: a retrospective study of 121 cases
H Samaha, C Dumontet, N Ketterer, et al.
The Journal of Rheumatology
|
February 11, 1999
Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes
P Duhaut, S Bosshard, A Calvet, et al.
British Journal of Cancer
|
September 15, 2001
Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity
C M Galmarini, N Falette, E Tabone, et al.
Leukemia Research
|
January 26, 2010
A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment
J-P Annereau, V Brel, C Dumontet, et al.
Cancer Research
|
June 30, 2001
Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis
A Mialhe, L Lafanechère, I Treilleux, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 16, 2011
Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains
A Doléans-Jordheim, E Bergeron, F Bereyziat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2006
Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
F Morschhauser, S Depil, E Jourdan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults
O Hequet, Q H Le, I Moullet, et al.
Page
of 11